163 related articles for article (PubMed ID: 2096296)
1. Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.
Angeli P; Brasili L; Cantalamessa F; Marucci G; Wess J
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):625-9. PubMed ID: 2096296
[TBL] [Abstract][Full Text] [Related]
2. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide.
Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M; Pigini M
J Med Chem; 1986 Sep; 29(9):1610-5. PubMed ID: 3746812
[TBL] [Abstract][Full Text] [Related]
3. Methoctramine selectively blocks cardiac muscarinic M2 receptors in vivo.
Wess J; Angeli P; Melchiorre C; Moser U; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):246-9. PubMed ID: 3057387
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic depression of synaptic transmission and blockade of norepinephrine-induced long-lasting potentiation in the dentate gyrus.
Burgard EC; Cote TE; Sarvey JM
Neuroscience; 1993 May; 54(2):377-89. PubMed ID: 7687752
[TBL] [Abstract][Full Text] [Related]
5. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
Ohno M; Yamamoto T; Watanabe S
Brain Res; 1994 Jul; 650(2):260-6. PubMed ID: 7953691
[TBL] [Abstract][Full Text] [Related]
6. Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.
Romanelli MN; Teodori E; Gualtieri F; Angeli P; Brasili L
J Med Chem; 1988 Sep; 31(9):1698-702. PubMed ID: 3411598
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon.
Grillner P; Bonci A; Svensson TH; Bernardi G; Mercuri NB
Neuroscience; 1999; 91(2):557-65. PubMed ID: 10366013
[TBL] [Abstract][Full Text] [Related]
8. Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfones.
Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M
J Med Chem; 1987 Oct; 30(10):1934-8. PubMed ID: 3656366
[TBL] [Abstract][Full Text] [Related]
9. The time course of transmitter release in mouse motor nerve terminals is differentially affected by activation of muscarinic M1 or M2 receptors.
Dudel J
Eur J Neurosci; 2007 Oct; 26(8):2160-8. PubMed ID: 17953614
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
Angeli P; Cantalamessa F; Gulini U; Melchiorre C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):304-7. PubMed ID: 8584046
[TBL] [Abstract][Full Text] [Related]
11. Methoctramine and hexahydrodifenidol antagonise two muscarinic responses on the rat superior cervical ganglion with opposite selectivity.
Field JL; Newberry NR
Neurosci Lett; 1989 May; 100(1-3):254-8. PubMed ID: 2761774
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
McKinney M; Anderson DJ; Vella-Rountree L; Connolly T; Miller JH
J Pharmacol Exp Ther; 1991 Jun; 257(3):1121-9. PubMed ID: 1646322
[TBL] [Abstract][Full Text] [Related]
13. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
Saito Y
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
[TBL] [Abstract][Full Text] [Related]
15. Functional and binding studies with muscarinic M2-subtype selective antagonists.
Lazareno S; Roberts FF
Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
[TBL] [Abstract][Full Text] [Related]
16. M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris-ciliary body.
Jumblatt JE; Hackmiller RC
Exp Eye Res; 1994 Feb; 58(2):175-80. PubMed ID: 7512511
[TBL] [Abstract][Full Text] [Related]
17. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive effect of an M2-selective muscarinic antagonist in anaesthetized guinea-pigs.
Howell RE; Kovalsky MP
J Auton Pharmacol; 1995 Feb; 15(1):19-26. PubMed ID: 7744887
[TBL] [Abstract][Full Text] [Related]
20. Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro.
Watson N; Barnes PJ; Maclagan J
Br J Pharmacol; 1992 Jan; 105(1):107-12. PubMed ID: 1596672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
